New Leaf Venture Partners, L.L.C. - X4 PHARMACEUTICALS INC ownership

X4 PHARMACEUTICALS INC's ticker is XFOR and the CUSIP is 98420X103. A total of 99 filers reported holding X4 PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
New Leaf Venture Partners, L.L.C. ownership history of X4 PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$365,150
-43.8%
335,0000.0%0.47%
-15.9%
Q2 2023$649,900
+123.0%
335,0000.0%0.56%
+131.5%
Q1 2023$291,450
-12.4%
335,0000.0%0.24%0.0%
Q4 2022$332,655
-41.9%
335,0000.0%0.24%
-29.1%
Q3 2022$573,000
+77.4%
335,0000.0%0.34%
+62.7%
Q2 2022$323,000
-44.9%
335,0000.0%0.21%
-27.7%
Q1 2022$586,000
-23.6%
335,0000.0%0.29%
+4.0%
Q4 2021$767,000
-56.7%
335,0000.0%0.28%
-45.6%
Q3 2021$1,772,000
-18.6%
335,0000.0%0.51%
-8.6%
Q2 2021$2,178,000
-24.5%
335,0000.0%0.56%
-16.7%
Q1 2021$2,884,000
+33.9%
335,0000.0%0.67%
+34.7%
Q4 2020$2,154,000
-5.0%
335,0000.0%0.50%
-45.5%
Q3 2020$2,268,000
-27.4%
335,0000.0%0.91%
+2.0%
Q2 2020$3,122,000
-6.8%
335,0000.0%0.90%
-10.6%
Q1 2020$3,350,000
-6.6%
335,0000.0%1.00%
+28.6%
Q4 2019$3,585,000
-1.0%
335,000
+17.5%
0.78%
-28.9%
Q3 2019$3,622,000
-15.3%
285,0000.0%1.10%
-4.4%
Q2 2019$4,275,000285,0001.15%
Other shareholders
X4 PHARMACEUTICALS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SV Health Investors, LLC 311,490$532,0001.65%
Bain Capital Life Sciences Investors, LLC 6,389,436$10,926,0001.30%
Tri Locum Partners LP 2,504,006$4,282,0001.18%
Sio Capital Management, LLC 1,418,461$2,426,0000.77%
NEA Management Company, LLC 6,523,157$11,155,0000.56%
AIGH Capital Management LLC 997,719$1,706,0000.53%
Parkman Healthcare Partners LLC 950,000$1,625,0000.46%
New Leaf Venture Partners, L.L.C. 335,000$573,0000.34%
Worth Venture Partners, LLC 250,144$428,0000.26%
Ikarian Capital, LLC 568,612$973,0000.19%
View complete list of X4 PHARMACEUTICALS INC shareholders